Global Fund To Stop Purchasing Generic Malaria Medication From Indian Manufacturer After U.S. Regulatory Warning

Reuters: India’s IPCA says Global Fund stops buying its anti-malarial drugs
“India’s IPCA Laboratories Ltd said on Thursday that the Global Fund to Fight AIDS, Tuberculosis and Malaria would no longer buy the company’s anti-malarial treatments after a U.S. regulatory warning about quality lapses at its factories…” (Wilkes, 4/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.